Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.37 USD | -1.80% | -12.25% | +76.92% |
05-23 | Transcript : Ventyx Biosciences, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 12:00 PM | |
05-16 | Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.92% | 314M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- VTYX Stock
- News Ventyx Biosciences, Inc.
- Transcript : Ventyx Biosciences, Inc., Q1 2024 Earnings Call, May 09, 2024